Clinical trial
A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive…
NCT00117247 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00117247 |
|---|---|
| Title | A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects |
| Official title | A Study to Assess the Pharmacokinetics and Pharmacodynamics of Repeat-Sose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Anemia, Congestive Heart Failure |
| Intervention type | Drug |
| Interventions | darbepoetin alfa |
| Start date | Jun 1, 2002 |
| Completion | Jul 1, 2004 |
| First posted | Jul 6, 2005 |
| Last update posted | Oct 16, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: